Latest GMI Study Abstracts

Latest GMI Study Abstracts

Morusin alleviates spinal cord injury.

Article Published Date : Jan 31, 2026
Study Type : Animal Study
Additional Links
Substances : Flavonoids : CK(5535) : AC(2653), Mulberry : CK(585) : AC(300)
Diseases : Lipopolysaccharide-Induced Toxicity : CK(3559) : AC(2075), Spinal Cord Injuries : CK(958) : AC(375)
Pharmacological Actions : Anti-Inflammatory Agents : CK(43668) : AC(17509), Neuroprotective Agents : CK(21754) : AC(8657)

Morusin targets DNA methyltransferase 1 to trigger senescence and sensitizes colorectal cancer to senolytic therapy.

Article Published Date : Jan 31, 2026
Study Type : Animal Study
Additional Links
Substances : Flavonoids : CK(5535) : AC(2653), White Mulberry : CK(220) : AC(91)
Diseases : Colorectal Cancer : CK(5144) : AC(2441)
Pharmacological Actions : Chemosensitizer : CK(1772) : AC(1353), Chemotherapeutic : CK(4561) : AC(1707)

Morusin attenuates myocardial ischemia/reperfusion injury.

Article Published Date : Feb 28, 2026
Study Type : Animal Study
Additional Links
Substances : Flavonoids : CK(5535) : AC(2653), White Mulberry : CK(220) : AC(91)
Diseases : Myocardial Ischemia : CK(1051) : AC(490), Oxidative Stress : CK(16513) : AC(6515)
Pharmacological Actions : Antioxidants : CK(37413) : AC(15719), Cardioprotective : CK(10073) : AC(3189), Heme oxygenase-1 up-regulation : CK(1492) : AC(865), Nrf2 activation : CK(3467) : AC(1975)

These findings highlight M. alba root bark as a promising source of lead compounds for the development of functional food ingredients or nutraceuticals targeting inflammation-related disorders.

Article Published Date : Jan 12, 2026
Study Type : Animal Study
Additional Links
Substances : White Mulberry : CK(220) : AC(91)
Diseases : Inflammation : CK(17298) : AC(5965)
Pharmacological Actions : Anti-Inflammatory Agents : CK(43668) : AC(17509), Immunomodulatory : CK(6995) : AC(2532)

Antibacterial and proteomic profiling of Morus alba extract against methicillin-resistant Staphylococcus aureus.

Article Published Date : Dec 31, 2025
Study Type : In Vitro Study
Additional Links
Substances : White Mulberry : CK(220) : AC(91)
Diseases : Staphylococcus aureus: Methicillin-resistant (MRSA) : CK(507) : AC(285)
Pharmacological Actions : Anti-Bacterial Agents : CK(4500) : AC(2145)
Additional Keywords : Plant Extracts : CK(19783) : AC(7256)

Morus alba L. (Sangzhi) alkaloids reduce polycystic ovary syndrome by improving hypothalamic-pituitary-ovarian axis function.

Article Published Date : Apr 24, 2026
Study Type : Human Study
Additional Links
Substances : White Mulberry : CK(220) : AC(91)
Diseases : Polycystic Ovary Syndrome : CK(2209) : AC(360)
Pharmacological Actions : Apoptotic : CK(10518) : AC(8130)

Neuroprotective effects of Morus alba ethanolic extract against rotenone-induced neurodegeneration and motor impairments in mouse model.

Article Published Date : Jan 31, 2026
Study Type : Animal Study
Additional Links
Substances : White Mulberry : CK(220) : AC(91)
Diseases : Neurodegenerative Diseases : CK(13800) : AC(4587), Oxidative Stress : CK(16513) : AC(6515)
Pharmacological Actions : Antioxidants : CK(37413) : AC(15719), Neuroprotective Agents : CK(21754) : AC(8657)
Additional Keywords : Plant Extracts : CK(19783) : AC(7256)

Polyphenol-rich Morus nigra L. extract mitigates neuroinflammation and cognitive impairment through gut-brain axis modulation in an Alzheimer's disease rat model.

Article Published Date : Dec 31, 2024
Study Type : Animal Study
Additional Links
Substances : Mulberry : CK(585) : AC(300)
Diseases : Alzheimer's Disease : CK(5678) : AC(2383), Brain Inflammation : CK(1932) : AC(996)
Pharmacological Actions : Neuroprotective Agents : CK(21754) : AC(8657)

Antioxidant, anti-cholinesterase, and neuroprotective properties of Morus alba and Morus nigra extracts.

Article Published Date : Apr 19, 2026
Study Type : In Vitro Study
Additional Links
Substances : Mulberry : CK(585) : AC(300)
Diseases : Cognitive Decline/Dysfunction : CK(5791) : AC(1156)
Pharmacological Actions : Antioxidants : CK(37413) : AC(15719), Cholinesterase Inhibitors : CK(41) : AC(30), Neuroprotective Agents : CK(21754) : AC(8657)

Black mulberry (Morus nigra L .) prevents deleterious effects of excess glucose in obese C. elegans decreasing lipofuscin accumulation and ROS production.

Article Published Date : Jan 29, 2025
Study Type : Animal Study
Additional Links
Substances : Mulberry : CK(585) : AC(300)
Diseases : Diabetes Mellitus: Type 2 : CK(13573) : AC(2708), Obesity : CK(11610) : AC(2816)
Pharmacological Actions : Alpha-amylase inhibitor : CK(286) : AC(191), Anti-Glycation Agents : CK(359) : AC(173), Antioxidants : CK(37413) : AC(15719)
Additional Keywords : Anti-Obesity Agents : CK(5518) : AC(1405)

Connect with GreenMedInfo

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2026 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.